NSIS-B.CO vs. HLN

Last updated Apr 3, 2026

Compare and contrast key facts about Novozymes A/S (NSIS-B.CO) and Haleon plc (HLN).

Performance

NSIS-B.CO vs. HLN - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in Novozymes A/S (NSIS-B.CO) and Haleon plc (HLN). The values are adjusted to include any dividend payments, if applicable.

NSIS-B.CO vs. HLN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
NSIS-B.CO Novozymes A/S	-3.86%	1.60%	10.91%	8.90%	-21.43%
HLN Haleon plc	0.04%	-4.80%	25.83%	1.34%	2.89%

Different Trading Currencies

NSIS-B.CO is traded in DKK, while HLN is traded in USD. To make them comparable, the HLN values have been converted to DKK using the latest available exchange rates.

Returns By Period

In the year-to-date period, NSIS-B.CO achieves a -3.86% return, which is significantly lower than HLN's 0.04% return.

NSIS-B.CO

• 1D: 1.25%
• 1M: 6.74%
• YTD: -3.86%
• 6M: 0.58%
• 1Y: -1.04%
• 3Y*: 5.14%
• 5Y*: 0.70%
• 10Y*: 4.48%

HLN

• 1D: 0.06%
• 1M: -5.79%
• YTD: 0.04%
• 6M: 13.66%
• 1Y: -6.26%
• 3Y*: 6.26%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NSIS-B.CO vs. HLN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NSIS-B.CO

NSIS-B.CO Risk / Return Rank: 35
NSIS-B.CO Sharpe Ratio Rank: 37
NSIS-B.CO Sortino Ratio Rank: 31
NSIS-B.CO Omega Ratio Rank: 31
NSIS-B.CO Calmar Ratio Rank: 39
NSIS-B.CO Martin Ratio Rank: 38

HLN

HLN Risk / Return Rank: 35
HLN Sharpe Ratio Rank: 38
HLN Sortino Ratio Rank: 31
HLN Omega Ratio Rank: 31
HLN Calmar Ratio Rank: 38
HLN Martin Ratio Rank: 38

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NSIS-B.CO vs. HLN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novozymes A/S (NSIS-B.CO) and Haleon plc (HLN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NSIS-B.CO	HLN	Difference
Sharpe ratio Return per unit of total volatility	-0.05	-0.27	+0.22
Sortino ratio Return per unit of downside risk	0.11	-0.23	+0.34
Omega ratio Gain probability vs. loss probability	1.01	0.97	+0.04
Calmar ratio Return relative to maximum drawdown	-0.01	-0.28	+0.27
Martin ratio Return relative to average drawdown	-0.03	-0.50	+0.47
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NSIS-B.CO vs. HLN - Sharpe Ratio Comparison

The current NSIS-B.CO Sharpe Ratio is -0.05, which is higher than the HLN Sharpe Ratio of -0.27. The chart below compares the historical Sharpe Ratios of NSIS-B.CO and HLN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NSIS-B.CO	HLN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.05	-0.27	+0.22
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.03	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.18	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.42	0.27	+0.16

Correlation

The correlation between NSIS-B.CO and HLN is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NSIS-B.CO vs. HLN - Dividend Comparison

NSIS-B.CO's dividend yield for the trailing twelve months is around 2.76%, more than HLN's 1.76% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NSIS-B.CO Novozymes A/S	2.76%	1.58%	0.98%	2.75%	1.56%	0.98%	1.50%	1.53%	1.55%	1.13%	1.44%	0.91%
HLN Haleon plc	1.76%	1.73%	1.65%	1.26%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

NSIS-B.CO vs. HLN - Drawdown Comparison

The maximum NSIS-B.CO drawdown since its inception was -52.31%, which is greater than HLN's maximum drawdown of -24.77%. Use the drawdown chart below to compare losses from any high point for NSIS-B.CO and HLN.

Drawdown Indicators

	NSIS-B.CO	HLN	Difference
Max Drawdown Largest peak-to-trough decline	-52.31%	-24.83%	-27.48%
Max Drawdown (1Y) Largest decline over 1 year	-29.44%	-23.11%	-6.33%
Max Drawdown (5Y) Largest decline over 5 years	-46.90%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-46.90%	—	—
Current Drawdown Current decline from peak	-21.70%	-12.44%	-9.26%
Average Drawdown Average peak-to-trough decline	-13.45%	-8.00%	-5.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	15.64%	12.57%	+3.07%

Volatility

NSIS-B.CO vs. HLN - Volatility Comparison

Novozymes A/S (NSIS-B.CO) has a higher volatility of 8.22% compared to Haleon plc (HLN) at 6.79%. This indicates that NSIS-B.CO's price experiences larger fluctuations and is considered to be riskier than HLN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NSIS-B.CO	HLN	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.22%	6.79%	+1.43%
Volatility (6M) Calculated over the trailing 6-month period	18.80%	16.33%	+2.47%
Volatility (1Y) Calculated over the trailing 1-year period	25.55%	23.01%	+2.54%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.42%	23.48%	+2.94%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.68%	23.48%	+2.20%

Financials